Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS

ABSTRACT:

SUBMITTER: Griffiths E 

PROVIDER: S-EPMC12343363 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature